School of Nursing and Allied Medical Sciences, Maragheh University of Medical Sciences, Maragheh, Iran.
Baku State University, Baku, Azerbaijan.
Neurol Sci. 2021 Jul;42(7):2653-2660. doi: 10.1007/s10072-021-05234-x. Epub 2021 Apr 12.
The World Health Organization (WHO) has declared that neurodegenerative diseases will be the biggest health issues of the twenty-first century. Among these, Alzheimer's and Parkinson's diseases can be considered as the most acute incurable neurological diseases. Researchers are studying and developing a new treatment approach that uses nanotechnology to diagnosis and treatment neurodegenerative diseases. This treatment strategy will be used to regress neurodegenerative diseases such as Alzheimer's disease. Alzheimer's disease (AD) is one of the most common forms of reduced brain function, which causes many devastating complications. Current neurodegenerative diseases treatment protocols only help to treat symptoms nevertheless with nanotechnology approaches, can regress nerve cells apoptosis, reduce inflammation, and improve brain drug delivery. In this paper, new nanotechnology methods such as nanobodies, nano-antibodies, and lipid nanoparticles have been investigated. Correspondingly blood-brain barrier drug delivery improvement methods have been suggested.
世界卫生组织(WHO)宣布,神经退行性疾病将成为 21 世纪最大的健康问题。在这些疾病中,阿尔茨海默病和帕金森病可以被认为是最严重的无法治愈的神经退行性疾病。研究人员正在研究和开发一种新的治疗方法,该方法利用纳米技术来诊断和治疗神经退行性疾病。这种治疗策略将用于逆转阿尔茨海默病等神经退行性疾病。阿尔茨海默病(AD)是最常见的大脑功能降低形式之一,它会导致许多严重的并发症。目前的神经退行性疾病治疗方案只能帮助治疗症状,但是利用纳米技术方法可以逆转神经细胞凋亡,减少炎症并改善大脑药物输送。本文研究了纳米抗体、纳米抗体和脂质纳米颗粒等新型纳米技术方法,并提出了改善血脑屏障药物输送的方法。